rTMS for chronic pain
Chronic nerve pain – after shingles, with polyneuropathy, after nerve injuries, after a stroke or with spinal cord damage – often responds only partially to medication. Repetitive transcranial magnetic stimulation (rTMS) of the motor cortex modulates pain processing in the brain and can reduce pain intensity without drug side effects.
We provide rTMS for pain as an addition to ongoing pain therapy – coordinated with your treating doctors and, if you are treated there, with the Schmerzzentrum Berlin in the same building.
Who rTMS may be suitable for
- Neuropathic pain for more than three months despite guideline-based medication – or when medication is not tolerated
- Central pain after stroke or spinal cord injury, phantom or stump pain
- Fibromyalgia, as an addition to exercise and behavioural therapy
- The diagnosis is established and the cause of the pain has been worked up
What we do
| Consultation | Pain history, neurological examination, check of indication and exclusion criteria, coordination with your treating clinicians, informed consent and a written cost estimate. |
|---|---|
| Protocol | High-frequency rTMS (10 Hz) over the motor cortex opposite the painful side; the target is determined individually (motor threshold, navigation). |
| Course | Induction with 10 to 15 sessions on consecutive working days over two to three weeks; afterwards maintenance sessions at increasing intervals as long as they help. A session takes about 30 minutes. |
| Follow-up | Pain diary and standardised scales (pain intensity, PROMIS pain interference) before, during and after the course; a summary report to your treating practice if you wish. |
What the evidence says
The European expert group led by Lefaucheur (Clinical Neurophysiology 2020) rates high-frequency rTMS of the motor cortex for neuropathic pain as level A evidence (“definite efficacy”); for fibromyalgia it is rated probably effective (level B). For other pain conditions the data are thinner and use is an individual decision.
In controlled trials, roughly 40 to 50 percent of patients achieve clinically meaningful pain relief (at least 30 percent); on average pain intensity falls by about a fifth to a third. The effect builds over the course and usually lasts for weeks after an induction series. These are group results; an individual outcome cannot be guaranteed.
Procedure, duration, costs
Limits and safety
rTMS is not possible with metallic or electronic implants in the head and is used only after careful consideration in people with pacemakers, epilepsy or an increased seizure risk. The most common side effects are transient headache and scalp discomfort; a seizure is very rare. Acute pain and pain of unclear cause are not an indication – there, diagnosis comes first.
Book a consultation +49 30 75633615
Related topics
This page provides general information and does not replace medical advice or an examination. Last updated: October 2026.
Next: Headache & migraine